Yeast Supplement Shows Promise in Enhancing Cancer-Fighting Immunity in Mice
Researchers at Trinity College Dublin and University College Dublin (UCD) have discovered that a yeast-based dietary supplement can enhance the immune response to cancer in laboratory mice. The study focused on obese mice, a group known to experience impaired immune function, and found that incorporating the yeast supplement into their diets altered the development of immune cells, leading to stronger responses against cancer. This finding is significant as obesity is known to hinder the body’s ability to effectively combat tumors.
The research, published in the journal Cell Reports, was led by Frederick Sheedy, an Associate Professor in Immunology at Trinity's School of Biochemistry and Immunology, alongside Helen Roche, a Professor in Nutrigenomics at UCD. Dr. Anna Ledwith, the postdoctoral researcher and first author of the study, explained that the team aimed to investigate whether yeast beta-glucan, a common dietary supplement, could reprogram early-stage immune cells in the bone marrow to produce long-lasting anti-tumor responses.
In their experiments, mice were fed either a standard or high-fat diet supplemented with yeast beta-glucan for a period of 4 to 12 weeks. Following this, their immune systems were challenged with various cancer cells, including those from colorectal, skin, and breast cancers. The researchers were particularly interested in whether the yeast supplement could mitigate immune dysfunction caused by obesity and if the protective effects would persist after weight loss.
The results indicated that dietary intake of yeast beta-glucan could trigger a form of trained immunity by modifying bone marrow stem cells, which had not been previously demonstrated with dietary interventions. Earlier studies had required injections to achieve similar immune training effects.
Professor Roche emphasized the importance of these findings, stating that this is the first demonstration that dietary delivery of yeast beta-glucan can induce trained immunity through reprogramming of bone marrow stem cells. The study also highlighted that the dietary intervention could restore anti-tumor innate immunity in obese mice, addressing long-term immune memory defects that can persist even after weight loss.
Obesity is a significant global health issue, affecting millions and disrupting immune function, which increases vulnerability to infections and cancer. The immune alterations associated with obesity can continue even after weight loss, presenting a challenge for recovery. The study's findings suggest that yeast beta-glucan may help reverse immune memory problems that linger post-weight loss.
As cancer remains one of the leading causes of death worldwide, researchers are exploring safe, accessible methods to restore immune function that could complement existing cancer treatments. Yeast beta-glucan is already marketed as a dietary supplement and is recognized for its safety, making it a viable candidate for future human studies.
Looking ahead, Professor Sheedy noted that this research opens the door for dietary intervention studies in individuals with obesity, chronic infections, and other conditions that compromise immune function. The specific yeast beta-glucan used in the study, WellmuneTM, is food-grade and commercially available, which could expedite clinical trials. Ultimately, this simple dietary supplement could enhance the immune system's ability to fight cancer, potentially improving responses to treatments such as chemotherapy and immunotherapy, as well as bolstering vaccine efficacy and infection resistance.




